When a patient presents with imaging evidence of a low grade glioma (LGG) a range of management options are available, including a wait and see policy, biopsy, resection, adjuvant therapy, or combinations of all of these approaches. There is currently no class 1 evidence to favour any particular approach. A randomised trial of early radiotherapy failed to show any difference in overall survival 1 . There is evidence from retrospective case series that gross total resection may carry an advantage in progression free survival [2] [3] [4] [5] . Deferring intervention remains a valid option in these patients to avoid treatment related morbidity, and the resultant reduced quality of life associated with treatment.
quality of life 7 , suggesting that intervention with at least a tissue diagnosis may be of benefit to patients' quality of life.
Patients with LGG will often have imaging and follow-up visits spanning many years; how patients function between these visits and to what level their diagnosis affects their life has not been studied. This study aims to explore the impact of a diagnosis of low grade glioma from the patients' perspective using qualitative research methodology to generate an understanding of the physical and emotional burden of a long term disease without cure and to address concerns regarding the uncertainty of the diagnosis and whether there is a need for upfront intervention.
PATIENTS AND METHODS

Study design
This was a prospective qualitative study using a single semistructured interview with patients followed by the senior author (MB) for presumed low grade glioma diagnosed by MR imaging.
Participants
All patients aged >18 with radiological evidence of a low grade glioma, who had not had prior biopsy, resection or adjuvant treatment were invited for interview. All patients had been followed for at least one year prior to interview. Thirty-five patients were identified from the senior authors' patient database as suitable for inclusion. Participants were invited for interview by telephone and provided with written information about the study. Those who agreed to participate were invited for face-toface interviews but telephone interviews were offered where distance precluded attendance. All interviews were conducted in a private room without the presence of relatives.
Data collection and analysis
Data collection and analysis in this qualitative study was based on grounded theory where ongoing data analysis leads to further questions to refine evolving theories 8 . As such interviews are conducted until no further themes emerge and saturation is reached, often between 25 -30 interviews 9 . An initial interview guide was developed and subsequent questions added as new themes emerged during the study (see Appendix).
Demographic data for each participant was collected including age, mode of presentation, occupation and duration of follow-up.
Verbatim transcripts of all interviews were prepared and then interview data were examined through modified thematic analysis, which includes open and axial coding 10 . Open coding involves breaking down information into common groupings based on shared ideas, while axial coding involves organizing information according to overarching themes. The transcriptions were analyzed by the investigators who contributed to development of the coding framework.
Research ethics
Informed consent was obtained from all participants. The study was approved by the Research Ethics Board of the University Health Network. 
RESULTS
Thirty-five patients were invited to participate and 30 volunteered for interview. A total of 24 patients were interviewed before saturation was reached and form the study cohort. The Table demonstrates the demographic data for each participant. The median age of participants was 47 (range 21 -82) and the median duration of follow-up 37 months (range 12 -156 months). Twelve patients (50%) presented with seizures, six presented with headaches and six were incidental findings.
Thematic Analysis
Analysis of the interview transcripts yielded five overarching themes:
Patients experience initial devastation followed by acceptance and low anxiety
All patients expressed shock and devastation at the initial diagnosis which dissipated quickly with subsequent imaging demonstrating no change in the lesion. Patients felt that the initial diagnosis represented imminent death and where relieved to be told that "wait and see" was an option. Most participants felt their anxiety and uncertainty about the future reduced after the second MRI or approximately one year. All patients reported that at approximately the one year stage they could resume their normal lives and make future plans again.
"After the first year as I saw it wasn't changed I relaxed and now I don't think about it anymore".
Serial imaging induces anxiety in most patients in the few days prior to the appointment but does not have an impact in the intervening time.
"As soon as I've found out it hasn't changed, it's over, that's it, bang!" Although patients reported that they became overtly anxious or withdrawn in the few days leading up to the next scan, none believed this had a negative impact on their life. "Anxious, I cry more readily, I get angry more easily. I worry that it's changed… I only worry for a few days before each appointment".
Absence of symptoms mitigates anxiety concerning the possibility of progression
Neurological symptoms are viewed as a direct marker of tumor behaviour and patients' perception of risk of progression is directly linked to the presence or absence of symptoms. Most patients at the time of interview were either asymptomatic or had seizures which were controlled on medication and were therefore happy to pursue a wait and see approach and not consider intervention.
"I worry that it's changed, but I focus more on the symptoms".
Most patients correlated symptoms to the severity of disease and were vigilant for potential symptoms at which point they felt that intervention would be warranted. "I'm guided by the symptoms I might expect and I don't have any".
Of those patients who presented with seizures (50%), where seizures were controlled on medication, most felt that medical treatment of their condition was sufficient. One patient has ongoing focal seizures, despite anticonvulsant therapy and has more anxiety regarding malignant progression than the rest of the participants.
Patients would prefer to defer surgery until there is progression or a change in their quality of life.
Overwhelmingly, given the option, all patients wished to pursue a wait and see approach, rather than consider upfront intervention. Most regarded the option of serial imaging as reassurance of the low grade nature of their lesion.
"I would take the wait and see option. Unless symptoms happened to take over and reduce my quality of life, but right now it's manageable". "Well, if it hasn't changed I'd leave it alone. As long as I'm symptom free there is no reason for me to have any surgery".
Although patients understand and accept that a radiological diagnosis has limitations, a biopsy and tissue diagnosis is of little value to patients independently. The issue of uncertainty has very little impact on patients. Eighty-five percent of participants stated that obtaining a histological diagnosis would not change their quality of life in any way.
"Knowing a name for it would make very little difference to me". 
Anxiety is reduced by trust in the physician
All patients were happy with the reassurance provided by their physician based on serial imaging, regarding the nature of the lesion. All those interviewed felt that they received enough information at follow-up visits and did not seek additional information on long-term prognosis.
"I had reassurance that it was likely benign, so I just carried on with life". Easy access to office visits and the ability to ask questions both at visits and in-between visits, via telephone or email, were significant factors in reducing anxiety in the long-term. While a minority of patients would be comfortable to have telephone follow-up for imaging results, most felt that face-to-face interaction and the ability to go through their scans with the physician was helpful to them.
However, when asked to consider upfront surgical intervention, the majority of patients stated that they would want firm evidence of benefit from early resection in terms of survival or seizure control, before accepting the risks of morbidity. "If you gave me statistics then I would consider it [surgery], but right now you can't guarantee it so I might as well stay as I am".
Quality of life is not affected by the diagnosis, as fear of morbidity from intervention is greater than the fear of uncertainty
All participants viewed themselves as healthy and most did not think their quality of life had been adversely affected by the diagnosis of LGG. Patients felt the greatest impact on their quality of life would be from neurological deficits associated with intervention. Very few patients expressed concerns regarding their own future and the implications of the diagnosis of a brain tumor. Most felt that the diagnosis alone had not had a negative impact on their lives or limited them in any way. In those presenting initially with seizures five (42%) felt that the diagnosis of epilepsy, with the need for ongoing medication and loss of their driving licence, had the greatest negative impact on their quality of life.
DISCUSSION
Using qualitative research methods to explore the issues of uncertainty and anxiety, we demonstrate that the wait and see policy without tissue diagnosis does not contribute to anxiety and reduced quality of life in patients with low grade glioma. Symptoms such as ongoing seizures have more negative impact than the uncertainty of tumor progression. The risk of surgery is not viewed as acceptable unless a definitive benefit is demonstrated, either in terms of prolonged survival or alleviation of symptoms.
Few studies in the literature address the cognitive and psychological impact of low grade glioma prior to any intervention. Two studies by Taphoorn et al 11, 12 focus on the effect of radiotherapy. Patients with LGG do not have significantly impaired performance status, but they do have cognitive impairment 11 . This cognitive impairment exists whether treatment has been undertaken or not, suggesting tumor infiltration and its psychological effects are responsible 12 . Fatigue is also a severe problem in patients with low grade glioma 13 . Patients with low grade glioma had significantly lower results on most neuropsychological variables than controls with hematological malignancy 14 . Mood states and well-being were significantly lower in patients with LGG than in healthy controls 15 . Where LGG has been managed conservatively it has been suggested that uncertainty regarding the diagnosis may influence cognitive performance and quality of life 7 . Reijneveld et al (2001) assessed cognitive performance and quality of life in patients with suspected LGG and those with proven (operated)
LGG, demonstrating that a wait and see policy had no negative impact on cognitive performance status or quality of life 16 . Using the Brain Cancer Module 20 questionnaire that study demonstrated no difference in the future uncertainty criteria between the two groups. Patients who underwent resection or biopsy scored worse on quality of life and cognitive status measures. The contribution of surgical morbidity to this difference in neuropsychological scores is difficult to assess. Qualitative research methodology is a potentially more sensitive tool to measure issues such as uncertainty, fear and its negative impact on quality of life. Our study demonstrates that in conservatively managed LGG fear of intervention has the greatest impact and that uncertainty is minimal. Overall all participants felt that their quality of life had not been affected by the diagnosis. Therefore our study and that of Reijneveld et al 16 conclude that a definitive diagnosis by biopsy does not lead to a reduction in anxiety or uncertainty and has no role in improving quality of life.
Qualitative research provides the ideal tool to learn more about the burden of a long-term disease process from the patient perspective. Edvardsson et al have used qualitative methodology to describe both patient and next-of kin perceptions of the onset and diagnosis of LGG, with particular emphasis on coping mechanisms [17] [18] [19] . Assessment of quality of life in LGG can be divided into broad categories: onset of illness, current life situation and experiences of encounters with health professionals. Edvardsson et al describe the onset of illness as the most distressing time 19 . This critical period at the initial diagnosis has a significant impact on the next of kin, which again dissipates over time 18 . Positive and negative experiences of encounters with healthcare professionals were strong themes in patient interviews, with repeated visits to multiple physicians contributing to distress 19 . Negative experiences involved lack of information. In our study patients were happy with the level of information they received. Continuity and trust was a significant theme contributing to reduction in anxiety levels in our study. Our study also highlights patient perceptions of the label 'low grade glioma', as highlighted by the patient quote 'I had reassurance that it was likely benign'. All patients are informed of the natural history of LGG and malignant transformation, but appear to perceive the adoption of the wait and see approach as evidence of a chronic nature of the disease.
Edvardsson et al demonstrated that being permitted to participate in and influence decisions regarding management was a significant positive theme 19 . This element of participation is also reflected in our study with patients reporting a wish to defer intervention until they themselves felt ready to accept the risk of additional morbidity. Our study is unique as it specifically addresses anxiety generated by the wait and see approach from the patients perspective, while previous studies have selected patients with a confirmed histological diagnosis who have undergone treatment.
Limitations
The potential limitations of the current study are that it represents a single institution experience of a group of conservatively managed patients with LGG. The results may not extend to other cultures, health care systems, and patient populations. The study cohort are potentially self selected as those radiological LGG lesions considered potentially more aggressive had already undergone intervention and are excluded from the study cohort. It is the senior author's policy to offer surveillance imaging and the wait and see approach in LGG patients unless treatment is indicated for clinical and/or imaging reasons (e.g. mass effect from the tumor) and/or the patient prefers treatment up-front. At the time of first presentation all patients are presented with all the options, including observation and surgery. In addition, the natural history of low grade glioma is explained, including malignant transformation. It is also explained that the senior authors' preference is surveillance imaging. It is clear from this study, that given these facts a large number of patients still wish to pursue a conservative approach, without a negative impact on their current lives. The study cohort demonstrates low levels of overall anxiety and minimal impact on quality of life in a population where it is postulated anxiety would have a major negative impact. For comparison, in the past five years 15 patients underwent surgery at initial diagnosis of low grade glioma, representing approximately 40% of the LGG cohort.
Another limitation is the potential for bias against up-front intervention by the interviewer but this is hopefully reduced by qualitative research methodology using semi-structured interviews which allows themes to freely emerge with minimal direction from the interviewer.
CONCLUSION
The findings from this study give valuable insight into patients' coping mechanisms when faced with a diagnosis of a suspected low grade glioma, beyond that obtained from Quality of Life measures used as adjuncts to clinical trials. Patients experience high levels of anxiety at the time of diagnosis, which rapidly dissipates. Overall, uncertainty or fear of future malignant progression has little impact on patients, who fear morbidity from treatment more than the prospect of future malignant progression, as long as it is felt that the wait and see approach is safe. This information is valuable when counselling patients on the management options in LGG, a disease in which there is no definitive evidence that up-front treatment confers improved survival.
(See Appendix on following page)
